(Q42234885)

19 October 2017

Transplacental rotavirus IgG interferes with immune response to live oral rotavirus vaccine ORV-116E in Indian infants (English)

1 reference

19 October 2017

0 references

0 references

1 reference

3

1 reference

19 October 2017

4

Sunita Taneja

1 reference

19 October 2017

6

Nita Bhandari

1 reference

19 October 2017

Mohan Babu Appaiahgari

1

1 reference

19 October 2017

Roger Glass

2

1 reference

19 October 2017

Temsunaro Rongsen-Chandola

5

1 reference

19 October 2017

Sukhdev Mishra

7

1 reference

19 October 2017

Sudhanshu Vrati

8

1 reference

19 October 2017

language of work or name

English

0 references

publication date

25 December 2013

1 reference

19 October 2017

1 reference

19 October 2017

32

1 reference

19 October 2017

6

1 reference

19 October 2017

651-656

1 reference

Oral rotavirus vaccines: how well will they work where they are needed most?

19 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.017

Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.017

Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.017

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.017

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.017

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.017

Rotavirus-specific breast milk antibody in two populations and possible correlates of interference with rhesus rotavirus vaccine seroconversion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.017

Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.017

High titers of circulating maternal antibodies suppress effector and memory B-cell responses induced by an attenuated rotavirus priming and rotavirus-like particle-immunostimulating complex boosting vaccine regimen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.017

Maternal antibodies to rotavirus: could they interfere with live rotavirus vaccines in developing countries?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.017

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.017

Safety and immunogenicity of two live attenuated human rotavirus vaccine candidates, 116E and I321, in infants: results of a randomised controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.017

Development of candidate rotavirus vaccines derived from neonatal strains in India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.017

Serum and salivary antibodies as indicators of rotavirus infection in neonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.017

Protection conferred by neonatal rotavirus infection against subsequent rotavirus diarrhea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.017

Neonatal Rotavirus Infection and Its Relation to Cord Blood Antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.017

A dose-escalation safety and immunogenicity study of live attenuated oral rotavirus vaccine 116E in infants: a randomized, double-blind, placebo-controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.017

Immunogenicity, reactogenicity and safety of human rotavirus vaccine (RIX4414) in Indian infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.017

A systematic review of anti-rotavirus serum IgA antibody titer as a potential correlate of rotavirus vaccine efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.017

Protective effect of preexisting rotavirus-specific immunoglobulin A against naturally acquired rotavirus infection in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.017

Prevalence of antibodies to rotavirus in different age-groups of infants in Bochum, West Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.017

Anti-rotavirus G type-specific and isotype-specific antibodies in children with natural rotavirus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.017

Epidemiological features of rotavirus infection in Caracas, Venezuela: implications for rotavirus immunization programs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.017

Acquisition of Serum Antibody to Norwalk Virus and Rotavirus and Relation to Diarrhea in a Longitudinal Study of Young Children in Rural Bangladesh

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.017

A comparison of the responses of 100 infants to primary poliomyelitis immunization with two and with three doses of vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.017

Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.017

Low titer maternal antibodies can both enhance and suppress B cell responses to a combined live attenuated human rotavirus and VLP-ISCOM vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.017

Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.017

Immunization against hepatitis A in the first year of life: priming despite the presence of maternal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.017

Immunogenicity of high-titre AIK-C or Edmonston-Zagreb vaccines in 3.5-month-old infants, and of medium- or high-titre Edmonston-Zagreb vaccine in 6-month-old infants, in Kinshasa, Zaire

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.017

Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.017

Safety, Immunogenicity, and Protective Efficacy of One and Three Doses of the Tetravalent Rhesus Rotavirus Vaccine in Infants in Lima, Peru

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.017

Reactogenicity and immunogenicity of a high-titer rhesus rotavirus-based quadrivalent rotavirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.017

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2013.12.017

1 reference

19 October 2017

1 reference